Similar differences were found between the nicotinamide group and the placebo group with respect to new basal-cell carcinomas ( @ % -LSB- @ % CI , -@ to @ -RSB- lower rate with nicotinamide , P = @ ) and new squamous-cell carcinomas ( @ % -LSB- @ % CI , @ to @ -RSB- lower rate , P = @ ) .